Eptifibatide
Product Images NDC 14335-070

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 14335-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hainan Poly Pharm. Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C1fc3a9b 57d5 6bcb E053 2995a90a6dac

Packaging label for Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) for intravenous use, supplied as a 1x100 mL single-dose vial. Manufactured by Hainan Poly Pharm. Co., Ltd. The label includes storage instructions, dosing guidance, and a barcode with NDC 14335-071-01. The product is intended for weight-adjusted infusion and is Rx only.*

FDA Label Image

C1fc3c67 A777 6c84 E053 2995a90af6ac

Label for Eptifibatide Injection 20 mg/10 mL (2 mg/mL) by Hainan Poly Pharm. Co., Ltd. The carton indicates a single-dose vial for intravenous use, weight-adjusted bolus dosing. Storage instructions specify refrigeration at 2-8°C with a transfer allowance up to 25°C for 2 months. The label includes dosage, contents, and distributor information for Slate Run Pharmaceuticals, LLC, Columbus, OH.*

FDA Label Image

Structural Formula (Image 01)

Chemical structure of Eptifibatide, showing its molecular framework including peptide bonds, amino groups, and a disulfide bond characteristic of this cyclic peptide compound.*

FDA Label Image

Figure 1 (Image 02)

A line graph comparing the percentage of patients with events over time (days) between two treatments, Eptifibatide and placebo. The x-axis represents time in days from 0 to 30, and the y-axis shows the percent of patients with events, ranging from 0 to 16%. The solid line represents Eptifibatide treatment, and the dashed line represents placebo treatment.*

FDA Label Image

Principal Display Panel (20 mg Carton Label)

The packaging label for Eptifibatide Injection 20 mg/10 mL (2 mg/mL) from Hainan Poly Pharm. Co., Ltd. It is indicated for weight-adjusted bolus dosing and comes in a single-dose vial. The label includes storage instructions, contents, and dosing notes, with a barcode and manufacturer details printed.*

FDA Label Image

Principal Display Panel (75 mg Carton Label)

Packaging label for Eptifibatide Injection 75 mg per 100 mL (0.75 mg/mL) for intravenous use only. The product comes as a 1 x 100 mL single-dose vial. Label shows the NDC number 14335-071-01 and details manufacturer Hainan Poly Pharm. Co., Ltd. and distributor Slate Run Pharmaceuticals, LLC. Includes storage instructions and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.